Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS
- PMID: 25010730
- PMCID: PMC4092131
- DOI: 10.1371/journal.ppat.1004154
Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.Adv Exp Med Biol. 2017;1018:91-127. doi: 10.1007/978-981-10-5765-6_7. Adv Exp Med Biol. 2017. PMID: 29052134 Review.
-
Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.Adv Virus Res. 2010;78:87-142. doi: 10.1016/B978-0-12-385032-4.00003-3. Adv Virus Res. 2010. PMID: 21040832 Free PMC article. Review.
-
Pathogenesis of AIDS--related Kaposi's sarcoma. Evidence of a viral etiology.Hematol Oncol Clin North Am. 1996 Oct;10(5):1011-21. doi: 10.1016/s0889-8588(05)70381-6. Hematol Oncol Clin North Am. 1996. PMID: 8880193 Review.
-
Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Cancer Lett. 2015 Jul 1;362(2):158-66. doi: 10.1016/j.canlet.2015.03.034. Epub 2015 Mar 30. Cancer Lett. 2015. PMID: 25837851 Free PMC article.
-
Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.Pathol Int. 2006 Oct;56(10):617-24. doi: 10.1111/j.1440-1827.2006.02017.x. Pathol Int. 2006. PMID: 16984619
Cited by
-
Targeting Kaposi's sarcoma associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases.Front Cell Dev Biol. 2023 Jan 17;11:1060156. doi: 10.3389/fcell.2023.1060156. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36733461 Free PMC article.
-
Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.PLoS Pathog. 2019 Dec 2;15(12):e1008156. doi: 10.1371/journal.ppat.1008156. eCollection 2019 Dec. PLoS Pathog. 2019. PMID: 31790497 Free PMC article.
-
Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy.BMC Cancer. 2023 Jan 20;23(1):71. doi: 10.1186/s12885-023-10540-y. BMC Cancer. 2023. PMID: 36670405 Free PMC article.
-
Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus.Virology. 2019 Oct;536:27-31. doi: 10.1016/j.virol.2019.07.028. Epub 2019 Jul 31. Virology. 2019. PMID: 31394409 Free PMC article.
-
DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma.PLoS One. 2020 May 14;15(5):e0233116. doi: 10.1371/journal.pone.0233116. eCollection 2020. PLoS One. 2020. PMID: 32407363 Free PMC article.
References
-
- Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865–1869. - PubMed
-
- Casper C (2011) The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med 62: 157–170. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical